Clearside Biomedical, Inc.

Company Listings from SPi: Clearside Biomedical, Inc.

You are here: Home >> SPi Company Listings >> Clearside Biomedical, Inc.

 

Clearside Biomedical, Inc.

Website:
http://

Search for other references to "clearside" on SPi News

Latest Clearside Biomedical, Inc. News

Clearside Biomedical to Present at the JMP Securities Life Sciences Conference ALPHARETTA, Ga., June 11, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and pres...... 12:05 GMT Tuesday 11th June 2019

Clearside Biomedical to Present at the UBS Global Healthcare Conference ALPHARETTA, Ga., May 15, 2019 (GLOBE NEWSWIRE) -- ­­Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and p...... 12:05 GMT Wednesday 15th May 2019

Clearside Biomedical Announces First Quarter 2019 Financial Results and Provides Corporate Update ALPHARETTA, Ga., May 08, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and prese...... 12:05 GMT Wednesday 8th May 2019

Clearside Biomedical’s Suprachoroidal Space Injection Platform Featured at Multiple Ophthalmology and Gene Therapy Medical Meetings ALPHARETTA, Ga., May 01, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and prese...... 12:05 GMT Wednesday 1st May 2019

Clearside Biomedical to Report First Quarter 2019 Financial Results and Provide Corporate Update on Wednesday, May 8, 2019 ALPHARETTA, Ga., April 25, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and pre...... 12:05 GMT Thursday 25th April 2019

Clearside Biomedical Announces Multiple Presentations on its Suprachoroidal Space® Injection Platform at Upcoming Medical Meetings ALPHARETTA, Ga., April 18, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and pre...... 12:05 GMT Thursday 18th April 2019

Clearside Biomedical Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update ALPHARETTA, Ga., March 12, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and pre...... 20:05 GMT Tuesday 12th March 2019

Clearside Biomedical to Present at the Cowen and Company 39th Annual Health Care Conference ALPHARETTA, Ga., March 04, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and pre...... 12:05 GMT Monday 4th March 2019

Clearside Biomedical to Report 2018 Financial Results and Provide Corporate Update on Tuesday, March 12, 2019 ALPHARETTA, Ga., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and pres...... 12:05 GMT Wednesday 27th February 2019

Clearside Biomedical Receives Notification of FDA Acceptance of NDA Filing for XIPERE™ (triamcinolone acetonide ophthalmic suspension) for Suprachoroidal Injection with PDUFA Date Set for October 19, 2019 ALPHARETTA, Ga., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and pres...... 12:05 GMT Wednesday 20th February 2019

Buy Clearside Biomedical, Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us